CP*Trends: An Online Tool for Comparing Cohort and Period Trends Across Cancer Sites

Am J Epidemiol. 2019 Jul 1;188(7):1361-1370. doi: 10.1093/aje/kwz089.

Abstract

Cohort or period components of trends can provide a rationale for new research or point to clues on the effectiveness of control strategies. Graphical display of trends guides models that quantify the experience of a population. In this paper, a method for smoothing rates by single year of age and year is developed and displayed to show the contributions of period and cohort to trends. The magnitude of the contribution of period and/or cohort in a model for trends may be assessed by the percentage of deviance explained and the relative contributions of cohort (C) and period (P) individually, known as the C-P score. The method is illustrated using Surveillance, Epidemiology, and End Results data (1975-2014) on lung and bronchial cancer mortality in females and prostate and colorectal cancer incidence in males. Smoothed age-period and age-cohort rates provide a useful first step in studies of etiology and the impact of disease control without imposing a restrictive model. We found that, in this data set, cohort predominates for female lung and bronchial cancer and period predominates for male prostate cancer. However, the effects change with age for male colorectal cancer incidence, indicating an age shift in relevant exposures. These methods are applied on an interactive website for both incidence and mortality at over 20 cancer sites in the United States.

Keywords: age-period-cohort models; cancer incidence; cancer mortality; cohort trends; period trends; smooth rates.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Bronchial Neoplasms / epidemiology
  • Bronchial Neoplasms / mortality*
  • Cohort Effect
  • Colorectal Neoplasms / epidemiology
  • Colorectal Neoplasms / mortality*
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Models, Statistical*
  • Population Surveillance / methods*
  • Prostatic Neoplasms / epidemiology
  • Prostatic Neoplasms / mortality*
  • SEER Program
  • United States / epidemiology